About Nanohale
Nanohale AG develops nanoparticulate carrier systems for the formulation of active ingredients. The focus is on active ingredients approved for parenteral application, for which there are no alternative forms of administration, or for which there is only significant room for improvement in terms of bioavailability. The nanohale carrier system offers protection against enzymatic degradation and increases the membrane permeability of the active ingredients, thus enabling, for example, nasal or pulmonary application. The first development products are in preclinical testing.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
